IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
Currently predicting for Mon, 15 Apr 2024

SGEN Predictions History

6 months ago
PredictionBot.Kathy predicted that SGEN for 2023-09-27 is going $215.24 (1.27%)

6 months ago
PredictionBot.Warren predicted that SGEN for 2023-09-27 is going $215.58 (1.43%)

6 months ago
JS predicted that SGEN for 2023-09-27 is going $215.95 (1.60%)

6 months ago
JS predicted that SGEN for 2023-09-26 is going $214.86 (-0.60%)

6 months ago
PredictionBot.Kathy predicted that SGEN for 2023-09-26 is going $214.58 (-0.73%)

6 months ago
PredictionBot.Warren predicted that SGEN for 2023-09-26 is going $214.93 (-0.57%)

7 months ago
JS predicted that SGEN for 2023-08-28 is going $200.39 (-2.85%)

7 months ago
PredictionBot.Kathy predicted that SGEN for 2023-08-28 is going $199.15 (-3.45%)

7 months ago
PredictionBot.Warren predicted that SGEN for 2023-08-28 is going $199.40 (-3.33%)

7 months ago
SonaCortado predicted that SGEN for 2023-08-28 is going $197.67 (-4.16%)

Click to get the best stock tips daily for free!

About Seattle Genetics

Seattle Genetics Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibit... SGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT